Log In
Print this Print this

TOBI Podhaler, Tobramycin inhalation powder (TIP)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionInhaled tobramycin powder
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPseudomonas
Indication DetailsTreat Pseudomonas aeruginosa infection in cystic fibrosis (CF) patients; Treat cystic fibrosis (CF) patients with chronic Pseudomonas lung infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today